Neurolens released the results of a double-masked, crossover peer-reviewed publication demonstrating that Neurolenses provide significant relief from headaches. In this multi-site study (10 optometry practices, 195 patients), Neurolenses demonstrated a statistically significant level of impact based on the widely used and validated Headache Impact Test, or HIT-6. These results were peer reviewed and published by Translational Vision Science & Technology, a highly regarded medical journal published by the Association of Research in Vision and Ophthalmology (ARVO). “This is a landmark moment, not just for Neurolens, but for the entire vision industry,” says Davis Corley, Neurolens CEO. “Neurolens is built on a clinical foundation, and we are pleased that a solution as simple and elegant as contoured prism lenses could expand the benefits of the annual eye exam. This study just reinforces what we already know: Neurolenses can change lives.”

–Andrew Karp